Evaluation of the migraine treatment sumatriptan/naproxen sodium on blood pressure following long-term administration.
Ontology highlight
ABSTRACT: Anti-inflammatory and pain therapies have been associated with blood pressure (BP) destabilization. Hence, the effects on BP of sumatriptan/naproxen sodium in fixed-dose combination, sumatriptan 85 mg, and naproxen sodium 500 mg administered intermittently for the acute treatment of migraine attacks were assessed. Patients with migraine with or without aura and no history of hypertension were randomized to sumatriptan/naproxen sodium (n=135), sumatriptan (n=136), or naproxen sodium (n=136) to treat migraine attacks for 6 months in a double-blind, parallel-group trial. Following a treated migraine attack, patients performed 2 consecutive days of self-measured BPs beginning ≥24 hours after the last dose of study medication and transmitted them by a transtelephonic modem. The primary end poin
SUBMITTER: White WB
PROVIDER: S-EPMC8108967 | biostudies-literature | 2011 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA